Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis.
Pigment Cell Melanoma Res. 2024 May;37(3):352-362. doi: 10.1111/pcmr.13156. Epub 2023 Dec 29.
Pigment Cell Melanoma Res. 2024.
PMID: 38158376
Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study.
Olsson Ladjevardi C, Koliadi A, Rydén V, Inan El-Naggar A, Digkas E, Valachis A, Ullenhag GJ.
Olsson Ladjevardi C, et al. Among authors: ryden v.
Cancer Med. 2023 Jun;12(12):13217-13224. doi: 10.1002/cam4.6013. Epub 2023 May 3.
Cancer Med. 2023.
PMID: 37132258
Free PMC article.
Item in Clipboard
Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR.
Liebman HA, et al. Among authors: ryden vm.
Cancer Treat Rep. 1983 May;67(5):413-9.
Cancer Treat Rep. 1983.
PMID: 6342771
Clinical Trial.
Item in Clipboard
Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project.
Chlebowski RT, Weiner JM, Luce J, Hestorff R, Lang JE, Reynolds R, Godfrey T, Ryden VM, Bateman JR.
Chlebowski RT, et al. Among authors: ryden vm.
Cancer Res. 1981 Nov;41(11 Pt 1):4399-403.
Cancer Res. 1981.
PMID: 7306966
Clinical Trial.
Item in Clipboard
Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspects.
Chlebowski RT, Chan KK, Tong MJ, Weiner JM, Ryden VM, Bateman JR.
Chlebowski RT, et al. Among authors: ryden vm.
Cancer. 1981 Sep 1;48(5):1088-95. doi: 10.1002/1097-0142(19810901)48:5<1088::aid-cncr2820480507>3.0.co;2-w.
Cancer. 1981.
PMID: 6268277
Clinical Trial.
Item in Clipboard
Factors influencing the interim interpretation of a breast cancer trial: danger of achieving the "expected" result.
Chlebowski RT, Weiner JM, Ryden VM, Bateman JR.
Chlebowski RT, et al. Among authors: ryden vm.
Control Clin Trials. 1981 Jun;2(2):123-32. doi: 10.1016/0197-2456(81)90003-9.
Control Clin Trials. 1981.
PMID: 7273791
Clinical Trial.
Item in Clipboard
Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.
Irwin LE, Chlebowski RT, Weiner JM, Reynolds R, Pugh RP, Ryden VM, Bateman JR.
Irwin LE, et al. Among authors: ryden vm.
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):981-4.
Cancer Treat Rep. 1980.
PMID: 7004635
Clinical Trial.
Item in Clipboard
Cite
Cite